Company Filing History:
1 out of 2 
1 out of 3 Years Active: 1992
Title: Gudmund Skjak-Brock: Innovator in Cytokine Stimulation
Introduction
Gudmund Skjak-Brock is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biopolymers, particularly in the stimulation of cytokine production. His work has implications for therapeutic applications, including vaccine adjuvants.
Latest Patents
Skjak-Brock holds a patent for "Diequatorially bound .beta.-1, 4 polyuronates and use of same." This invention focuses on a material and method for stimulating the production of cytokines. The patent details how various polysaccharides, such as polymers of D-mannuronic acid, chitosan, and cellulose, can induce human monocytes to produce cytokines. The molecular weights of the polysaccharides are crucial for their effectiveness, with poly-M and chitosan needing to exceed 50,000 and 20,000, respectively. The invention has therapeutic utility as vaccine adjuvants and components, potentially enhancing antibody production in response to vaccine antigens.
Career Highlights
Throughout his career, Skjak-Brock has worked with several organizations, including Nobipols Forskningsstiftelse and Protan Biopolymer AS. His research has focused on the development of biopolymers and their applications in medicine and biotechnology.
Collaborations
Skjak-Brock has collaborated with notable colleagues, including Marit Otterlei and Terje Espevik. These partnerships have contributed to the advancement of research in cytokine stimulation and biopolymer applications.
Conclusion
Gudmund Skjak-Brock's innovative work in cytokine stimulation and biopolymers has the potential to impact therapeutic strategies significantly. His contributions to the field are noteworthy and continue to inspire further research and development.